Antibiotics in pregnancy influence nasal microbiome and respiratory morbidity in infancy.

Rüttimann, Céline; Nissen-Kratzert, Annika; Mostacci, Nadja; Künstle, Noëmi; Marten, Andrea; Gisler, Amanda; Bacher, Katharina; Yammine, Sophie; Steinberg, Ruth; Schulzke, Sven; Röösli, Martin; Latzin, Philipp; Hilty, Markus; Frey, Urs; Gorlanova, Olga (2023). Antibiotics in pregnancy influence nasal microbiome and respiratory morbidity in infancy. ERJ Open Research, 9(4) European Respiratory Society 10.1183/23120541.00225-2023

[img]
Preview
Text
00225-2023.full.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC).

Download (933kB) | Preview

BACKGROUND

The effects of prenatal antibiotic exposure on respiratory morbidity in infancy and the involved mechanisms are still poorly understood. We aimed to examine whether prenatal antibiotic exposure in the third trimester is associated with nasal microbiome and respiratory morbidity in infancy and at school age, and whether this association with respiratory morbidity is mediated by the nasal microbiome.

METHODS

We performed 16S ribosomal RNA gene sequencing (regions V3-V4) on nasal swabs obtained from 296 healthy term infants from the prospective Basel-Bern birth cohort (BILD) at age 4-6 weeks. Information about antibiotic exposure was derived from birth records and standardised interviews. Respiratory symptoms were assessed by weekly telephone interviews in the first year of life and a clinical visit at age 6 years. Structural equation modelling was used to test direct and indirect associations accounting for known risk factors.

RESULTS

α-Diversity indices were lower in infants with antibiotic exposure compared to nonexposed infants (e.g. Shannon index p-value 0.006). Prenatal antibiotic exposure was also associated with a higher risk of any, as well as severe, respiratory symptoms in the first year of life (risk ratio 1.38, 95% CI 1.03-1.84; adjusted p-value (padj)=0.032 and risk ratio 1.75, 95% CI 1.02-2.97; padj=0.041, respectively), but not with wheeze or atopy in childhood. However, we found no indirect mediating effect of nasal microbiome explaining these clinical symptoms.

CONCLUSION

Prenatal antibiotic exposure was associated with lower diversity of nasal microbiome in infancy and, independently of microbiome, with respiratory morbidity in infancy, but not with symptoms later in life.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Service Sector > Institute for Infectious Diseases > Research
04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine
04 Faculty of Medicine > Service Sector > Institute for Infectious Diseases
04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine > Paediatric Pneumology

Graduate School:

Graduate School for Cellular and Biomedical Sciences (GCB)

UniBE Contributor:

Bacher, Katharina, Yammine, Sophie, Steinberg, Ruth Theresia, Latzin, Philipp, Hilty, Markus, Frey, Urs Peter

Subjects:

600 Technology > 610 Medicine & health
500 Science > 570 Life sciences; biology

ISSN:

2312-0541

Publisher:

European Respiratory Society

Language:

English

Submitter:

Pubmed Import

Date Deposited:

01 Sep 2023 11:33

Last Modified:

09 Jan 2024 14:30

Publisher DOI:

10.1183/23120541.00225-2023

PubMed ID:

37650088

BORIS DOI:

10.48350/185945

URI:

https://boris.unibe.ch/id/eprint/185945

Actions (login required)

Edit item Edit item
Provide Feedback